Free Trial

Sensei Biotherapeutics (SNSE) SEC Filings & 10K Form

$0.85
+0.02 (+2.41%)
(As of 05/29/2024 ET)

Recent Sensei Biotherapeutics SEC Filings

DateFilerForm TypeView
05/23/2024
4:10 PM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:37 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
3:35 PM
Sensei Biotherapeutics (Filer)
Form DEFA14A
04/29/2024
3:40 PM
Sensei Biotherapeutics (Filer)
Form ARS
04/12/2024
3:31 PM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
6:45 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
5:00 PM
Newtyn Management, LLC (Filed by)
Sensei Biotherapeutics (Subject)
Form SC 13D/A
02/29/2024
3:44 PM
Sensei Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2024
6:31 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
5:25 PM
Colgan Erin (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
5:28 PM
Celebi John (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
5:37 PM
Sensei Biotherapeutics (Issuer)
van der Horst Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
4:34 PM
Newtyn Management, LLC (Filed by)
Sensei Biotherapeutics (Subject)
Form SC 13D/A
01/04/2024
7:14 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
3:40 PM
Sensei Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2023
6:35 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2023
5:07 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:50 PM
Krebs Stephanie (Reporting)
Sensei Biotherapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/02/2023
3:53 PM
Krebs Stephanie (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2023
4:01 PM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2023
7:43 AM
Celebi John (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
4:31 PM
Colgan Erin (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
4:33 PM
Celebi John (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
4:33 PM
Sensei Biotherapeutics (Issuer)
van der Horst Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
4:34 PM
Gallagher Patrick Stephen (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2023
4:15 PM
Sensei Biotherapeutics (Filer)
Form 424B5
08/04/2023
3:41 PM
Cambrian BioPharma Inc (Filed by)
Sensei Biotherapeutics (Subject)
Form SC 13G/A
08/03/2023
3:32 PM
Sensei Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2023
7:45 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2023
4:00 PM
Broder Samuel (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
4:02 PM
RICKS THOMAS G (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
4:03 PM
RINGO WILLIAM R (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
3:44 PM
Holmen Bob (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
3:46 PM
Sensei Biotherapeutics (Issuer)
Vojta Deneen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
3:48 PM
English Jessie (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
3:50 PM
Humer Kristian (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2023
3:31 PM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2023
8:00 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2023
3:30 PM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2023
3:41 PM
Sensei Biotherapeutics (Filer)
Form ARS
06/15/2023
3:31 PM
Sensei Biotherapeutics (Filer)
Form DEF 14A
This Apple-like Innovator is Revolutionizing Healthcare (Ad)

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SNSE) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners